{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T20:50:15Z","timestamp":1781988615094,"version":"3.54.5"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,20]]},"DOI":"10.7759\/cureus.111206","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T20:23:51Z","timestamp":1781987031000},"source":"Crossref","is-referenced-by-count":0,"title":["Managing Antithrombotic Treatment in Intracerebral Hemorrhage and Ischemic Stroke Due to Cerebral Amyloid Angiopathy With Supporting Pathology"],"prefix":"10.7759","author":[{"given":"Chelsea Mae N","family":"Nobleza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene Marie P","family":"Bustamante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibet Marie Y","family":"Sih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond L","family":"Rosales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120866","article-title":"Exploring cerebral amyloid angiopathy: insights into pathogenesis, diagnosis, and treatment","volume":"454","author":"Cozza M","year":"2023","unstructured":"Cozza M, Amadori L, Boccardi V. Exploring cerebral amyloid angiopathy: insights into pathogenesis, diagnosis, and treatment. J Neurol Sci. 2023, 454:120866. 10.1016\/j.jns.2023.120866","journal-title":"J Neurol Sci"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00208-3","article-title":"The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study","volume":"21","author":"Charidimou A","year":"2022","unstructured":"Charidimou A, Boulouis G, Frosch MP, et al.. The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol. 2022, 21:714-25. 10.1016\/S1474-4422(22)00208-3","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2015.88","article-title":"Ischemic brain injury in cerebral amyloid angiopathy","volume":"36","author":"Reijmer YD","year":"2016","unstructured":"Reijmer YD, van Veluw SJ, Greenberg SM. Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab. 2016, 36:40-54. 10.1038\/jcbfm.2015.88","journal-title":"J Cereb Blood Flow Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0000000000000411","article-title":"Antithrombotic therapy in patients with cerebral microbleeds","volume":"30","author":"Wilson D","year":"2017","unstructured":"Wilson D, Werring DJ. Antithrombotic therapy in patients with cerebral microbleeds. Curr Opin Neurol. 2017, 30:38-47. 10.1097\/WCO.0000000000000411","journal-title":"Curr Opin Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.28.7.1418","article-title":"Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy","volume":"28","author":"Greenberg SM","year":"1997","unstructured":"Greenberg SM, Vonsattel JP. Diagnosis of cerebral amyloid angiopathy: sensitivity and specificity of cortical biopsy. Stroke. 1997, 28:1418-22. 10.1161\/01.str.28.7.1418","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott T","year":"1989","unstructured":"Brott T, Adams HP Jr, Olinger CP, et al.. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989, 20:864-70. 10.1161\/01.str.20.7.864","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.92.15_supplement.P5.3-037","article-title":"Simultaneous ischemic stroke and intracerebral hemorrhage due to amyloid angiopathy presenting as a therapeutic challenge (P5.3-037)","volume":"92","author":"Amin M","year":"2019","unstructured":"Amin M, Jillella D, Uchino K. Simultaneous ischemic stroke and intracerebral hemorrhage due to amyloid angiopathy presenting as a therapeutic challenge (P5.3-037). Neurology. 2019, 92:10.1212\/WNL.92.15_supplement.P5.3-037","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ana.27253","article-title":"Prevalence of cerebral amyloid angiopathy and associated risk of subsequent ischemic and hemorrhagic stroke and mortality in a nationwide cohort","volume":"98","author":"Bruce SS","year":"2025","unstructured":"Bruce SS, Zhang C, Liberman AL, et al.. Prevalence of cerebral amyloid angiopathy and associated risk of subsequent ischemic and hemorrhagic stroke and mortality in a nationwide cohort. Ann Neurol. 2025, 98:249-57. 10.1002\/ana.27253","journal-title":"Ann Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000201723","article-title":"Stroke risk and antithrombotic treatment during follow-up of patients with ischemic stroke and cortical superficial siderosis","volume":"100","author":"Mart\u00ed-F\u00e0bregas J","year":"2023","unstructured":"Mart\u00ed-F\u00e0bregas J, Camps-Renom P, Best JG, et al.. Stroke risk and antithrombotic treatment during follow-up of patients with ischemic stroke and cortical superficial siderosis. Neurology. 2023, 100:e1267-81. 10.1212\/WNL.0000000000201723","journal-title":"Neurology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000327887.64299.a4","article-title":"Impaired visual evoked flow velocity response in cerebral amyloid angiopathy","volume":"71","author":"Smith EE","year":"2008","unstructured":"Smith EE, Vijayappa M, Lima F, Delgado P, Wendell L, Rosand J, Greenberg SM. Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology. 2008, 71:1424-30. 10.1212\/01.wnl.0000327887.64299.a4","journal-title":"Neurology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.96.15_supplement.2680","article-title":"Incident ischemic stroke and intracranial hemorrhage in patients with cerebral amyloid angiopathy on aspirin versus none (2680)","volume":"96","author":"Jamali S","year":"2021","unstructured":"Jamali S, Lin M. Incident ischemic stroke and intracranial hemorrhage in patients with cerebral amyloid angiopathy on aspirin versus none (2680). Neurology. 2021, 96:2680. 10.1212\/WNL.96.15_supplement.2680","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa275","article-title":"New horizons: managing antithrombotic dilemmas in patients with cerebral amyloid angiopathy","volume":"50","author":"Kelly J","year":"2021","unstructured":"Kelly J. New horizons: managing antithrombotic dilemmas in patients with cerebral amyloid angiopathy. Age Ageing. 2021, 50:347-55. 10.1093\/ageing\/afaa275","journal-title":"Age Ageing"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)30840-2","article-title":"Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial","volume":"393","year":"2019","unstructured":"Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART). a randomised, open-label trial. Lancet. 2019, 393:2613-23. 10.1016\/S0140-6736(19)30840-2","journal-title":"Lancet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.023855","article-title":"Cilostazol versus aspirin in ischemic stroke patients with high-risk cerebral hemorrhage: subgroup analysis of the PICASSO trial","volume":"51","author":"Kim BJ","year":"2020","unstructured":"Kim BJ, Kwon SU, Park JH, et al.. Cilostazol versus aspirin in ischemic stroke patients with high-risk cerebral hemorrhage: subgroup analysis of the PICASSO trial. Stroke. 2020, 51:931-7. 10.1161\/STROKEAHA.119.023855","journal-title":"Stroke"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21061992","article-title":"Potential therapeutic approaches for cerebral amyloid angiopathy and Alzheimer's disease","volume":"21","author":"Tanaka M","year":"2020","unstructured":"Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M. Potential therapeutic approaches for cerebral amyloid angiopathy and Alzheimer's disease. Int J Mol Sci. 2020, 21:1992. 10.3390\/ijms21061992","journal-title":"Int J Mol Sci"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442513-managing-antithrombotic-treatment-in-intracerebral-hemorrhage-and-ischemic-stroke-due-to-cerebral-amyloid-angiopathy-with-supporting-pathology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T20:23:53Z","timestamp":1781987033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442513-managing-antithrombotic-treatment-in-intracerebral-hemorrhage-and-ischemic-stroke-due-to-cerebral-amyloid-angiopathy-with-supporting-pathology"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,20]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.111206","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,20]]}}}